Company Overview of EDP Biotech Corporation
EDP Biotech Corporation, a medical device company, engages in the development and sale of immunodiagnostic tests for humans and animals. It identifies and purifies proteins in the early stages of biological changes for the production of in vitro diagnostic tests. The company’s ColoMarker test is a tool for early detection of Colon Cancer through a sample of blood. The company was founded in 2005 and is based in Knoxville, Tennessee.
6701 Baum Drive
Knoxville, TN 37919
Founded in 2005
Key Executives for EDP Biotech Corporation
Chief Executive Officer and Director
Chief Administrative Officer
Vice President of Business Development
Vice President of Research and Development
Compensation as of Fiscal Year 2015.
EDP Biotech Corporation Key Developments
EDP Biotech Corporation Announces CE Mark Approval for ColoMarker an in Vitro Diagnostic Aid in Early Detection of Colon Cancer and Plans for Commercialization in Europe
Sep 30 14
EDP Biotech Corporation has announced CE Mark approval for ColoMarker, an aid in early detection of Colon Cancer. This is a critical step toward commercialization of this unique product which will initially be introduced in the thirty member states belonging to the European Economic Area (EEA). The EDP ColoMarker test is a quick and easy tool for clinicians as an aid in early detection of colon cancer when it is most treatable, and only requires a small sample of blood. EDP expects that ColoMarker's affordable cost (priced somewhere between IFOBT and FIT stool tests), effectiveness, and the convenience of a whole blood test will significantly improve compliance compared to colonoscopy-based cancer screenings and existing fecal testing options.
EDP Biotech Corporation Announces Board Appointments
Sep 15 14
EDP Biotech Corporation announced that Dr. William (Bill) H. West and former Chairman, President and CEO of Regions Financial Corporation, Jackson (Jack) W. Moore will be joining the company’s esteemed board of directors. Dr. William (Bill) H. West is the Founder-Emeritus of the West Clinic in Memphis, Tenn. Dr. West is board certified in internal medicine and medical oncology, and has a career long interest in healthcare delivery systems. Jackson (Jack) W. Moore is a Director of Methodist LeBonheur Healthcare., and is also the retired Executive Chairman, President and CEO of Regions Financial Corporation. Mr. Moore currently serves as the Vice Chairman of the Board of Trustees at Vanderbilt University.
EDP Biotech Plans to Commercialize ColoMarker
Jul 9 13
EDP Biotech announced its plans to commercialize the product and bring the new technology to market. Unlike other diagnostic tests currently in development, the ColoMarker test detects a level of CA11-19 antigen, a specific protein molecule found in the bloodstream. While every human being produces this protein, elevated levels in the bloodstream suggest the presence of colon cancer. ColoMarker(TM) has proven to be effective in identifying elevated levels of a biomarker in the bloodstream in 95% of early stage colorectal cancers, when the disease is most treatable and survival rates are highest. To date, physicians have relied primarily on colonoscopies and fecal occult blood testing (FOBT) to identify potential cases of early stage colon cancer.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
Sponsored Financial Commentaries